Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricCICignaCVSCVS HealthDGXQuest Diagnostics
Snapshot
Price$275.05$87.62$236.27
Market cap$76.12B$133.62B$23.88B
Valuation
P/E11.6x37.8x25.4x
Forward P/E8.9x54.1x22.1x
Growth
Revenue growth8.8%7.6%11.0%
EPS growth30.5%-46.0%14.9%
Profitability
Net margin2.3%0.7%9.1%
ROE15.2%3.9%14.1%
Balance sheet & cash
Debt / equity0.75x0.86x0.82x
Free cash flow yield9.7%9.9%5.4%
Dividend yield2.1%2.6%1.7%
Verdict
Investment ratingFavorable· 60Weak· 36Neutral· 52

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearCItoday $275CVStoday $88DGXtoday $236
2027$269.14 – $394.74+44% CAGR$67.03 – $98.31+12% CAGR$203.57 – $298.57+26% CAGR
2028$351.15 – $515.02+37% CAGR$68.37 – $100.28+7% CAGR$233.86 – $343.00+20% CAGR
2029$458.15 – $671.95+35% CAGR$69.74 – $102.28+5% CAGR$268.66 – $394.03+19% CAGR
2030$597.74 – $876.69+34% CAGR$71.13 – $104.33+4% CAGR$308.64 – $452.67+18% CAGR
2031$779.88 – $1,143.82+33% CAGR$72.55 – $106.41+4% CAGR$354.56 – $520.02+17% CAGR
5-yr CAGR23.2% – 33.0%-3.7% – 4.0%8.5% – 17.1%